NCT02157714: Multiple Ascending Dose Study of PRX002 in Patients With Parkinson's Disease
- State
- Completed
- Phase
- Phase 1
- People
- 64 planned
- Started
- Jun 2014
- Primary completion
- Sep 2016
- Arms
- PRX002
- Results
- None posted
- Papers
- doi:10.1001/jamaneurol.2018.1487, doi:10.1002/mds.26878
- 6 Jun 2014: Trial registered
- 21 Oct 2016: Trial completed